Evidence map›Paper›PMID 29475966›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

Social Relationships, Inflammation, and Cancer Survival.

Courtney E Boen, David A Barrow, Jeannette T Bensen, Laura Farnan, Adrian Gerstel, Laura H Hendrix, Yang Claire Yang

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06987708 (Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers Associated With Monoclonal Gammopathy of Unknown Significance), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06987708 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers Associated With Monoclonal Gammopathy of Unknown Significance (MGUS) and Smoldering Myeloma (SM): A Prospective Intervention Pilot Study

TypeinterventionalSponsorHackensack Meridian HealthRan2026 to 2028Enrolled67ConditionsMonoclonal Gammopathy of Uncertain Significance, Smoldering MyelomaArmsThe Multimodal Lifestyle Intervention
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Social Support Buffers the Effect of Social Deprivation on Comorbidity Burden in Adults with Cancer.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Healing Broken Bones and Fixing Fractured Connections.The journal of behavioral health services & research · 2023
    Article
  17. Article
  18. Article
  19. Patients' perspectives on the effect of the COVID-19 pandemic on access to cancer care and social contacts in Sweden and the UK: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Courtney E BoenDepartment of Sociology and Population Studies Center, University of Pennsylvania, Philadelphia, Pennsylvania. cboen@upenn.edu.
David A BarrowUNC Cytokine & Biomarker Analysis Facility, School of Dentistry, University of North Carolina Chapel Hill, Chapel Hill, North Carolina.
Jeannette T BensenDepartment of Epidemiology, Gillings School of Public Health, University of North Carolina Chapel Hill, Chapel Hill, North Carolina.
Laura FarnanLineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, North Carolina.
Adrian GerstelLineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, North Carolina.
Laura H HendrixDuke Cancer Institute/Alliance for Clinical Trials in Oncology, Durham, North Carolina.
Yang Claire YangLineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, North Carolina.
University of North Carolina at Chapel Hill · USAlliance for Clinical Trials in Oncology · USUniversity of Pennsylvania · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
POPULATION STUDIEST32HD007168 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ELIZABETH A FRANKENBERG · 1985 to 2026
$13.8M
Carolina Population CenterR24HD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MORGAN, SAMUEL PHILIP · 2005 to 2014
$10.0M
Population Science Research Center Development CoreR24HD044964 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI SMITH, HERBERT L. · 2003 to 2017
$9.8M
Sci-Tech Core-Population Dynamics Research CenterP2CHD044964 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI EMILIO ALBERTO PARRADO · 2018 to 2026
$5.3M
NCI NIH HHS P30 CA016086NICHD NIH HHS P2C HD044964NICHD NIH HHS R24 HD044964NICHD NIH HHS R24 HD050924NICHD NIH HHS T32 HD007168NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Social SupportBiomarkers, TumorCancer SurvivorsC-Reactive ProteinFemaleHumansInterleukin-6MaleMiddle AgedNeoplasmsPatient SatisfactionRegistriesStress, PsychologicalSurveys and QuestionnairesTumor Necrosis Factor-alphaBiomarkers, TumorC-Reactive ProteinIL6 protein, humanInterleukin-6TNF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID29475966
PMCPMC5932225
OpenAlexW2788784814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.